Aug 17, 2020 / 03:00AM GMT
Operator
Ladies and gentlemen, good day, and welcome to the Q1 FY '21 Earning Conference Call of Glenmark Pharmaceuticals Limited.
(Operator Instructions) Please note that this conference is being recorded.
I would now like to hand the conference over to Mr. Jason D'souza. Thank you, and over to you, sir.
Jason D'souza - Glenmark Pharmaceuticals Limited - Senior VP & Head of Corporate Strategy
Thank you, Janice. Apologies for the delay in the earnings call. We had a problem with the audio bridge. We'll begin Glenmark's Q1 Earnings Call.
Before we start the review of the operations for the quarter ended June 30, 2020. For the first quarter FY '21, Glenmark's consolidated revenue was at INR 23,447 million, recording an increase of 0.94%.
Business update on account of the COVID situation. The COVID-19 pandemic had a significant impact in India, as the entire country was under lockdown in April and most part of May. While the pharmaceutical plants being essential services were allowed to operate, it was challenging
Q1 2021 Glenmark Pharmaceuticals Ltd Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot